PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

被引：0
|
作者：
Karin Beelen
Mark Opdam
Tesa M Severson
Rutger HT Koornstra
Andrew D Vincent
Jelle Wesseling
Jettie J Muris
Els MJJ Berns
Jan B Vermorken
Paul J van Diest
Sabine C Linn
机构：
[1] The Netherlands Cancer Institute,Departments of Molecular Biology
[2] The Netherlands Cancer Institute,Departments of Biometrics
[3] The Netherlands Cancer Institute,Departments of Pathology
[4] Erasmus University Medical Center- Cancer Center,Department of Medical Oncology
[5] Antwerp University Hospital,Department of Medical Oncology
[6] University Medical Center Utrecht,Department of Pathology
[7] The Netherlands Cancer Institute,Departments of Medical Oncology
来源：
Breast Cancer Research | / 16卷
关键词：
Tamoxifen; Molecular Alteration; PIK3CA Mutation; Adjuvant Tamoxifen; Endocrine Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor
    A. Tavakkol
    J. Varani
    J. T. Elder
    Ch. C. Zouboulis
    Archives of Dermatological Research, 1999, 291 : 643 - 651
  • [32] Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor
    Tavakkol, A
    Varani, J
    Elder, JT
    Zouboulis, CC
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (12) : 643 - 651
  • [33] Molecular alterations of epidermal growth factor receptor and PIK3CA in uterine serous carcinoma
    Hayes, Monica Prasad
    Douglas, Wayne
    Ellenson, Lora Hedrick
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S30 - S30
  • [34] Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance
    Knowlden, Janice M.
    Jones, Helen E.
    Barrow, Denise
    Gee, Julia M. W.
    Nicholson, Robert I.
    Hutcheson, Iain R.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (01) : 79 - 91
  • [35] Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance
    Janice M. Knowlden
    Helen E. Jones
    Denise Barrow
    Julia M. W. Gee
    Robert I. Nicholson
    Iain R. Hutcheson
    Breast Cancer Research and Treatment, 2008, 111 : 79 - 91
  • [36] The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Sato, Katsuaki
    Takemoto, Toshiki
    Iwasaki, Takuya
    Mitsudomi, Tetsuya
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (04) : 1002 - 1006
  • [37] Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer
    Lee, AV
    Cui, XJ
    Oesterreich, S
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4429S - 4435S
  • [38] Targeting the insulin-like growth factor-1 receptor in human cancer
    Arcaro, Alexandre
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [39] Targeting the insulin-like growth factor receptor pathway in breast cancer
    Yee, D
    Sachdev, D
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S4
  • [40] Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
    Tian, Dan
    Mitchell, Isaiah
    Kreeger, Pamela K.
    BMC SYSTEMS BIOLOGY, 2016, 10
12345